Glaxosmithkline Share Price | |
---|---|
Price | 1,610.50 |
Bid | 1,607.50 |
Ask | 1,608.00 |
Change | -33.00 (-2.01%) |
Volume | 8,908,641 |
Open | 1,626.50 |
High | 1,626.50 |
Low | 1,594.50 |
Prev. Close | 1,643.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £65.81b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 11,701 |
---|---|
Vol. Sold | 1,493,412 |
Sold Value | £22.90m |
Vol. Bought | 4,403,202 |
Bought Value | £69.16m |
PE Ratio | 13.24424 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.446% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
16-Apr-24 | 18:20:03 | 1,611.51 | 4,328 | Unknown* | 1,607.50 | 1,608.00 | 69.75k | O Ordinary Was reported as OTC |
16-Apr-24 | 18:09:02 | 1,604.871 | 114,188 | Unknown* | 1,607.50 | 1,608.00 | 2m | O Ordinary Was reported as OTC |
16-Apr-24 | 18:07:36 | 1,602.13727 | 425 | Unknown* | 1,607.50 | 1,608.00 | 6,809 | O Ordinary Was reported as OTC |
16-Apr-24 | 18:07:47 | 1,610.844 | 6,221 | Unknown* | 1,607.50 | 1,608.00 | 100.21k | O Ordinary Was reported as OTC |
16-Apr-24 | 18:07:47 | 1,611.161 | 262 | Unknown* | 1,607.50 | 1,608.00 | 4,221 | O Ordinary Was reported as OTC |
16-Apr-24 | 18:07:46 | 1,609.92 | 349 | Unknown* | 1,607.50 | 1,608.00 | 5,619 | O Ordinary Was reported as OTC |
16-Apr-24 | 18:07:27 | 1,606.969 | 111,705 | Unknown* | 1,607.50 | 1,608.00 | 2m | O Ordinary Was reported as OTC |
16-Apr-24 | 18:06:39 | 1,605.108 | 182,728 | Unknown* | 1,607.50 | 1,608.00 | 3m | O Ordinary Was reported as OTC |
16-Apr-24 | 18:02:18 | 1,610.50 | 78 | Unknown* | 1,607.50 | 1,608.00 | 1,256 | O Ordinary Was reported as OTC |
16-Apr-24 | 18:02:18 | 1,610.50 | 118 | Unknown* | 1,607.50 | 1,608.00 | 1,900 | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Vishal Sikka held the position of Independent Non-Executive Director at the time of this trade.Vishal Sikka | 40.96 | USD | 43 | 253,466,508 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Jesse Goodman held the position of Independent Non-Executive Director at the time of this trade.Jesse Goodman | 40.96 | USD | 9 | 11,157 |
At GSK, we unite science, technology and talent to get ahead of disease together